Kazia Therapeutics Limited American Depositary Shares (KZIA)
PHARMACEUTICAL PREPARATIONS
Kazia Therapeutics Limited American Depositary Shares (KZIA) is listed on Nasdaq, where it has traded since January 6, 1999.
- Listed On
- Nasdaq
- Listed Since
- January 6, 1999
- Employees
- 6
- Market Cap
- $149M
About Kazia Therapeutics Limited American Depositary Shares
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 36 institutions reported holding KZIA, with 3.6 million shares worth $50.7 million in aggregate. The largest reported holder was Boxer Capital Management, with 560,000 shares worth $7.9 million. Of the 5 largest holders listed below, 2 opened new positions in KZIA, 2 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Boxer Capital Management | 560,000 | $8M | New position |
| Flputnam Investment Management | 414,958 | $6M | Added 191.26% |
| Bleichroeder | 400,000 | $6M | Unchanged |
| Ikarian Capital | 396,201 | $6M | New position |
| Dauntless Investment Group | 354,208 | $5M | Added 343.69% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is KZIA?
Kazia Therapeutics Limited American Depositary Shares (KZIA) is listed on Nasdaq, where it has traded since January 6, 1999.
Who are the largest institutional holders of KZIA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of KZIA were Boxer Capital Management, Flputnam Investment Management and Bleichroeder.
How many institutions own KZIA?
36 institutions reported a position in KZIA for the quarter ended June 30, 2026, worth $50.7 million in total.
Did institutions buy or sell KZIA last quarter?
Of the 5 largest reported holders, 2 opened new positions in KZIA, 2 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for KZIA.
Every reported institutional holder, plus insider and congressional trades in KZIA, on SentiSense.